Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention

Topol, 2000, Recognition of the importance of embolization in atherosclerotic vascular disease, Circulation, 101, 570, 10.1161/01.CIR.101.5.570

Califf, 1998, Myonecrosis after revascularization procedures, J Am Coll Cardiol, 31, 241, 10.1016/S0735-1097(97)00506-8

Johansen, 1998, Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements, Eur Heart J, 19, 112, 10.1053/euhj.1997.0732

Bonz, 2002, Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial), J Am Coll Cardiol, 21

Akkerhuis, 2002, Minor myocardial damage and prognosis, Circulation, 105, 554, 10.1161/hc0502.104278

Stone, 2001, Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention, Circulation, 104, 642, 10.1161/hc3101.093902

Colombo, 2002, Nothing is lower than 0, and 3 is closer to 0 than to 5—medicine is not arithmetic, Eur Heart J, 23, 840, 10.1053/euhj.2001.3148

Ellis, 2002, Death following creatine kinase-MB elevation after coronary intervention, Circulation, 106, 1205, 10.1161/01.CIR.0000028146.71416.2E

Pettiti, 1999

Kini, 1999, Incidence and mechanism of creatine kinase-MB enzyme elevation after coronary intervention with different devices, Catheter Cardiovasc Intervent, 48, 123, 10.1002/(SICI)1522-726X(199910)48:2<123::AID-CCD1>3.0.CO;2-O

Brener, 2002, Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality, J Am Coll Cardiol, 40, 1961, 10.1016/S0735-1097(02)02538-X

Harrington, 1995, Characteristics and consequences of myocardial infarction after percutaneous coronary intervention, J Am Coll Cardiol, 25, 1693, 10.1016/0735-1097(95)00091-H

Kugelmass, 1994, Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting, Am J Cardiol, 74, 748, 10.1016/0002-9149(94)90427-8

Baim, 1998, Final results of the Balloon vs Optimal Atherectomy Trial (BOAT), Circulation, 97, 322, 10.1161/01.CIR.97.4.322

Kong, 1997, Prognostic implication of creatine kinase elevation following elective coronary artery interventions, JAMA, 277, 461, 10.1001/jama.1997.03540300029029

Abdelmeguid, 1996, Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions, Am Heart J, 131, 1097, 10.1016/S0002-8703(96)90083-6

Abdelmeguid, 1996, Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions, Circulation, 94, 1528, 10.1161/01.CIR.94.7.1528

Abdelmeguid, 1995, Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure, Circulation, 91, 2733, 10.1161/01.CIR.91.11.2733

Saucedo, 2000, Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting, J Am Coll Cardiol, 35, 1134, 10.1016/S0735-1097(00)00513-1

Tardiff, 1999, Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention, J Am Coll Cardiol, 33, 88, 10.1016/S0735-1097(98)00551-8

Simoons, 1999, Minimal myocardial damage during coronary intervention is associated with impaired outcome, Eur Heart J, 20, 1112, 10.1053/euhj.1999.1521

Gruberg, 2001, Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure, Am J Cardiol, 87, 1356, 10.1016/S0002-9149(01)01552-1

Fuchs, 2000, Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions, Am J Cardiol, 85, 1077, 10.1016/S0002-9149(00)00699-8

Dangas, 2002, Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention, Am J Cardiol, 89, 586, 10.1016/S0002-9149(01)02299-8

Lincoff, 1999, Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab, Circulation, 99, 1951, 10.1161/01.CIR.99.15.1951

Narins, 1999, The relationship between periprocedural myocardial infarction and subsequent target vessel revascularization following percutaneous coronary revascularization, J Am Coll Cardiol, 33, 647, 10.1016/S0735-1097(98)00620-2

Hong, 1999, Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality, Circulation, 100, 2400, 10.1161/01.CIR.100.24.2400

Jeremias, 2002, Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction, Am Heart J, 143, 1040, 10.1067/mhj.2002.122124

Brener, 2002, Frequency and long-term impact of myonecrosis after coronary stenting, Eur Heart J, 23, 869, 10.1053/euhj.2001.2976

Alpert, 2000, Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction, J Am Coll Cardiol, 36, 959, 10.1016/S0735-1097(00)00804-4

Karvouni, 2003, Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions, J Am Coll Cardiol, 41, 26, 10.1016/S0735-1097(02)02666-9